These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17471861)

  • 1. [Myth and realities of antifibrotic medication].
    Kershenobich D
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():60-1. PubMed ID: 17471861
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifibrotic therapy of liver cirrhosis, with special reference to primary biliary cirrhosis: promises and limitations.
    Jansen PL
    Neth J Med; 1992 Apr; 40(3-4):209-14. PubMed ID: 1603214
    [No Abstract]   [Full Text] [Related]  

  • 3. [Site of liver fibrosis and an attempt to control it].
    Takahashi T; Fujisawa K; Tanaka T; Kubo T; Kimura A
    Saishin Igaku; 1969 Jan; 24(1):181-3. PubMed ID: 5777188
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the potential role of antifibrotic agents for the treatment of liver disease?
    Schnabl B; Scholten D; Brenner DA
    Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):496-7. PubMed ID: 18628735
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrogenesis in cirrhosis. Potential for therapeutic intervention.
    Rojkind M
    Pharmacol Ther; 1992; 53(1):81-104. PubMed ID: 1641403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis.
    Malhotra A; Naniwadekar A; Sood G
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1942. PubMed ID: 19120880
    [No Abstract]   [Full Text] [Related]  

  • 7. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
    Ciesek S; Manns MP; Wedemeyer H
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):337-50. PubMed ID: 18043552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.
    Popov Y; Schuppan D
    Hepatology; 2009 Oct; 50(4):1294-306. PubMed ID: 19711424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhosis reversal: a duel between dogma and myth.
    Desmet VJ; Roskams T
    J Hepatol; 2004 May; 40(5):860-7. PubMed ID: 15094237
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive agents in treatment of liver cirrhosis: personal experience].
    Laurent J; Mauuary G; Bas M; Vautrin D; Drouin P; Gaucher P; Heully F
    Acta Gastroenterol Belg; 1968 Nov; 31(11):780-5. PubMed ID: 5746039
    [No Abstract]   [Full Text] [Related]  

  • 11. Regression of cirrhosis of the liver detected by elastiometry.
    Mössner BK; Biagini M; Pedersen C; Christensen PB
    Scand J Gastroenterol; 2008; 43(11):1401-2. PubMed ID: 18615357
    [No Abstract]   [Full Text] [Related]  

  • 12. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats.
    Işeri SO; Sener G; Saglam B; Ercan F; Gedik N; Yeğen BC
    Regul Pept; 2008 Feb; 146(1-3):73-9. PubMed ID: 17884193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic options in the inflammatory bowel disease world.
    Noble A; Baldassano R; Mamula P
    Dig Liver Dis; 2008 Jan; 40(1):22-31. PubMed ID: 17988966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, hepatitis C, and liver transplantation.
    Alsatie M; Pandya P; Chalasani NP
    Liver Transpl; 2008 Feb; 14(2):136-7. PubMed ID: 18236446
    [No Abstract]   [Full Text] [Related]  

  • 16. [When can TNF-alpha inhibitors against inflammatory bowel disease be withdrawn?].
    Moum B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1673. PubMed ID: 17571118
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
    van de Nadort C; Houwen RH; Stapelbroek JM
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):490. PubMed ID: 18030221
    [No Abstract]   [Full Text] [Related]  

  • 19. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
    Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
    J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?
    Haghikia A; Gold R
    Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.